References

  1. Roux F, D'Ambrosio C, Mohensin V. Sleep-related breathing disorders and cardiovascular disease. Am J Med. 2000; 108(5):396-402. PubMed | Google Scholar

  2. Okosieme OE, Morse RE. Pseudophaeochromocytoma in two young Africans. J R Soc Med. 2004; 97(12):583-4. PubMed | Google Scholar

  3. Stradling JR, Pepperell JCT, Davies RJO. Sleep apnoea and hypertension: proof at last? Thorax. 2001;56(2):45-9. PubMed | Google Scholar

  4. Mann SJ. Severe paroxysmal hypertension (pseudopheochromocytoma). Curr Hypertens Rep. 2008;10(1):12-8. PubMed | Google Scholar

  5. Hedner J, Ejnell H, Sellgren J, Hender T, Wallin G. Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? J Hypertens. 1988;6(4):529-31. PubMed | Google Scholar

  6. Krentz AJ, Mikhail S, Cantrell P, Hill GM. Drug Points: Pseudophaeochromocytoma syndrome associated with clozapine. BMJ. 2001; 322(7296):1213. PubMed | Google Scholar

  7. Smith ML, Pacchia CF. Sleep apnoea and hypertension: role of chemoreflexes in humans. Exp Physiol. 2007; 92(1):45-50. PubMed | Google Scholar

  8. Hoy LJ, Emery H, Wedzicha JA, et al. Obstructive sleep apnea present¬ing as pseudopheochromocytoma: a case report. J Clin Endocrinol Metab. 2004;89(5):2033-8. PubMed | Google Scholar

  9. Minemura H, Akashiba T, Yamamoto H, et al. Acute effects of nasal continuous positive airway pressure on 24-hour blood pressure and catecholamines in pa¬tients with obstructive sleep apnea. Intern Med. 1998;37(12):1009-13. PubMed | Google Scholar